Bosutinib (Phase 1 part) ( DrugBank: Bosutinib )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
2筋萎縮性側索硬化症1

2. 筋萎縮性側索硬化症


臨床試験数 : 645 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04744532
(ClinicalTrials.gov)
March 19, 20199/1/2021iPSC-based Drug Repurposing for ALS Medicine (iDReAM) StudyPhase 1/2 Study of Bosutinib in Patients With Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral SclerosisDrug: Bosutinib (Phase 1 part);Drug: Bosutinib (Phase 2 part)Kyoto UniversityTokushima University;Kitasato University;Tottori University;Nara Medical University;Toho University;Hiroshima University;PfizerRecruiting20 Years75 YearsAll49Phase 1/Phase 2Japan